NYSE · FTK

Flotek Industries, Inc.

$25.84 -$0.10 (-0.39%) 1D Market open

Key Metrics

$938.44M
Market cap
31.48×
P/E · TTM
$251.95M
Revenue · TTM
$29.81M
Net income
EPS · TTM $0.94
Dividend yield
Free cash flow
Beta · 1Y 1.63
EBITDA · TTM $22.70M
Gross margin 25.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    A material event was filed (Form 8-K).

    8-K - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 2
    The stock moved +14.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 2
  • May 13
    The stock moved +10.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$938.44M
Enterprise value$972.77M
Shares outstanding36.2M
52-wk range$10.95 – $28.50
Avg volume · 20D174.6K
Net cash −$34.32M
Book value / share$3.72
IndustryMiscellaneous Chemical Products
ExchangeNYSE
About Flotek Industries, Inc.
IPO dateOct 16, 1996
Employees160

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E31.48
P/S3.72
P/FCF
EV/EBITDA42.86
EV/Sales3.86
Graham №$8.87

Profitability

Gross 25.0%
Operating 8.1%
Net 11.8%
FCF
ROE / ROIC 25.7% · 19.5%

Financial Health

Current ratio1.83
Quick ratio1.62
Debt / equity0.34
Debt / EBITDA 1.76
Net cash −$34.32M
Working capital$57.07M

Cash Flow · TTM

Operating CF −$88.00K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

4.9
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$8.87 vs $25.84
Trades 2.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings